Related Experiment Video
Updated: Mar 15, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Non-coding RNAs: Therapeutic Strategies and Delivery Systems
1Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. hling@mdanderson.org.
Noncoding RNAs, including microRNAs and long noncoding RNAs, are promising therapeutic targets for cancer. Effective delivery systems are crucial for developing novel noncoding RNA therapeutics.
Area of Science:
- Genetics
- Molecular Biology
- Pharmacology
Background:
- The human genome extensively transcribes noncoding RNAs, such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs).
- Dysregulation of miRNAs in cancers has spurred interest in their therapeutic potential as drugs and drug targets.
- lncRNAs are emerging as therapeutic targets due to their roles in complex phenotypes and protein output regulation.
Purpose of the Study:
- To discuss general therapeutic strategies targeting noncoding RNAs.
- To review delivery systems for enhancing noncoding RNA therapeutic efficacy.
- To offer perspectives on noncoding RNA-targeting agents for colorectal cancer.
Main Methods:
- Review of preclinical studies on oligonucleotide-based miRNA mimicking and blocking.
- Analysis of chemical modifications and delivery systems for nucleic acid therapeutics.
- Exploration of therapeutic strategies for noncoding RNAs.
Main Results:
- miRNA therapeutics have entered clinical trials for various diseases, including cancer.
- Challenges remain in the effective and safe delivery of nucleic acid therapeutics.
- Various delivery systems and chemical modifications are being developed to improve efficacy and reduce side effects.
Conclusions:
- Noncoding RNAs represent a significant area for therapeutic development.
- Advancements in delivery systems are critical for realizing the potential of noncoding RNA therapeutics.
- Future development of noncoding RNA targeting agents holds promise for diseases like colorectal cancer.
More Related Videos
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Related Concept Videos
Types of RNA
RNA Performs Diverse...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Experimental RNAi